The United States has struck a deal with Swiss pharmaceutical giants Novartis and Roche to lower drug prices, according to media reports. +Get the most important news from Switzerland in your inbox The deal is expected to be made public on Friday, Bloomberg reports, citing sources close to the matter. + Read how Trump upended the pharma industry According to the news agency, the agreement could be part of a broader announcement involving other pharmaceutical groups, but the details have not yet been finalised. The aim would be to relieve companies of the threat of customs duties in return for a reduction in the prices of certain drugs. The discussions are linked to the easing of the trade dispute between Switzerland and the US, after the parties announced a week ago a reduction in customs duties from 39% to 15% on imports from Switzerland retroactive to November 14. Medicines are excluded from the tariffs, but US President Donald Trump has repeatedly threatened to impose levies and …